In addition to general articles on clinical aspects of diabetes mellitus, Diabetes & Metabolic Syndrome: Clinical Research
and Reviews also presents articles on basic research in all areas of diabetes the Metabolic Syndrome. Topics covered relevant to
the diabetic patient will include diagnosis, pathogenesis, and clinical management of: diabetes related complications such as retinopathy,
neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence,
etc. All aspects relating to hypertension, dyslipidemia, obesity and atherosclerosis will also be relevant to the journal. Diabetes & Metabolic Syndrome: Clinical Research and Reviews will also publish papers on the general pathogenesis and prevention of diabetes.
Criteria for initial considerations for papers submitted will be originality, statistical provability of all data, and applicability
to the aims of the Journal as a whole. All potentially acceptable manuscripts will be subjected to the process of peer review. To aid
with the peer review process, please include names, addresses, (email), phone and fax numbers for all individuals suggested to review
the manuscript.
To increase the usefulness of Diabetes & Metabolic Syndrome: Clinical Research & Reviews to the
readership, submissions in the following categories, will be deemed appropriate for consideration by the Editors and Editorial Board:
Editorials: Comments by organizations or individuals on topics of current interest will be by invitation only.
Original Science
and Research manuscripts
Review Articles: Critical presentations of topics of interest to those active in the prevention and
management of diabetesand its attendant complications, hypertension, obesity, dyslipidemia, atherosclerosis and all other aspects and
components of the Metabolic Syndrome .
Invited Commentaries: Including hypotheses, perspectives, Observations, items for debate,
position statements, etc.
Clinical Care: Aspects dealing with all aspects and issues in the management of patients with diabetes,
hypertension, obesity, dyslipidemias and the Metabolic Syndrome.
Case Reports: Limited to the presentation and discussion of
cases that help advance our understanding of diabetes and the Metabolic Syndrome and its components.
Rapid Communications.
Letters to the Editor: Responses to previous articles and editorials.
Announcements: Announcements to pertinent forthcoming
meetings or events.
MANUSCRIPTS: Manuscripts may be submitted using online submissions ( see below) or can be sent by email
or through mail.
If online submissions is not used, the manuscripts should be typewritten, double-spaced, using a standard sized typeface
and margins of at least one inch. Place two returns after every element, such as title, headings, paragraphs, and figure and table callouts.
Manuscripts are accepted for publication with the understanding that their contents, or their essential substance, have not been published
elsewhere, except in abstract form or by the express consent of the Editors. Materials taken from other sources must be accompanied by
written permissions for reproduction, obtained from the original publisher. Statistical methods should be identified. Priority claims
are discouraged. Acknowledgments of aid or criticism should be approved by the person whose help is being recognized. Grantors may be
listed at the conclusion of the text.
Papers can also be submitted using the online submission system.
The Author Gateway is
a journal author's one-stop shop to:
Submit your papers online
Track the status of your submission - from decision
to publication
Stay informed of new journal content & books
Create your own personalized home page
Concise,
relevant and intuitive, the Author Gateways' tools facilitate easy, timely and high quality publication of your important work.
Author
Support is our front-line link between journal authors and the Elsevier production process. This helpdesk service can help authors
with questions on pre-publication, production and post-production processes for both hard copy and online submissions.
CONFLICT
OF INTEREST POLICY: Authors are required to disclose commercial or similar relationships to products or companies mentioned in or
related to the subject matter of the article being submitted. Sources of funding for the article should be acknowledged in a footnote
on the title page. Affiliations of authors should include corporate appointments relating to or in connection with products or companies
mentioned in the article, or otherwise bearing on the subject matter thereof. Other pertinent financial relationships, such as consultancies,
stock ownership or other equity interests or patent-licensing arrangements, should be disclosed to the Editor-in-Chief in the cover letter
at the time of submission. Such relationships may be disclosed in the Journal at the discretion of the Editor-in-Chief in footnotes appearing
on the title page. Questions about this policy should be directed to the Editor-in-Chief.
TITLE PAGE: On the title page include
title; subtitle (if any); first name, middle initial, and last names of each author, with academic degrees; name of Department(s) and
Institution(s) to which the work should be attributed; disclaimer(s) (if any); name and address of author to whom requests for reprints
should be sent. The address, telephone and fax numbers of the person responsible for negotiations concerning the manuscripts should be
listed separately and clearly labelled as such. Authors will be required to sign a statement conferring the manuscript copyright to Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
ABSTRACT AND KEY WORDS: An abstract of 100 to 250 words for
articles (including reviews), or 50 to 100 words for brief communications, should be typed double-spaced on a separate page. It should
cover the main factual points, including statements of the problem, methods, results, and conclusions. The abstract should be accompanied
by a list of three to five key words for indexing purposes.
TEXT: Headings and subheadings should be provided in the methods
and results, and where appropriate in the discussion sections. Please keep the text clear and concise. Because the readership of Diabetes & Metabolic Syndrome: Clinical Research & Reviews spans many disciplines, jargon should be avoided, as it may not be familiar
to some readers.
ABBREVIATIONS: Use standard abbreviations and units recommended in the Style Manual for Biological Journals
(Fourth edition, Arlington, Va., American Institute of Biological Sciences, 1978). Nonstandard abbreviations should be defined the first
time they appear in the text.
DRUG NAMES: Generic names should be used. Proprietary names may be given (parenthetically) with
the first use of the generic name.
REFERENCES: References should be numbered consecutively (with square brackets) as they appear
in the text. The reference list should be in the form shown by the three examples below.
Examples:
[1] The F DECODE Study Group,
Glucose tolerance and mortality:
comparison of WHO and American Diabetes Association
diagnostic criteria, Lancet 354 (1999) 617-621.
[2] J.L. Chiasson, R. Gomis, M. Hanefeld, R.G. Josse, A. Karasik,
M. Laakso, The STOP-NIDDM trial: an international study on
the efficacy
of an alpha-glucosidase inhibitor to prevent type 2
diabetes in a population with impaired glucose tolerance:
rationale, design, and
preliminary screening data, Diab. Care
21 (1998) 1720-1725.
[3] R.E. Pratley, C. Weyer, The role of impaired early insulin
secretion
in the pathogenesis of type II diabetes mellitus,
Diabetologia 44 (2001) 929-945.
Please note that all authors should be listed
when six or less; when seven or more, list only the first six and add et al. Do not include references to personal communications, unpublished
data or manuscripts either in preparation or submitted for publication. If essential, such material may be incorporated into the appropriate
place in the text. Titles of journals should be abbreviated according to the International Organisation for Standardization's (1985)
List of Serial Title Word Abbreviations, Geneva. Recheck references in the text against the reference list before your manuscript is
accepted.
TABLES: Tables should be typed, double-spaced, on separate sheets with number (Roman) and title. Symbols for units
should be confined to column headings. Abbreviations should be kept to a minimum, and those used, explained.
REVIEW AND ACTION:
All contributions (including solicited articles) are critically reviewed by the Editors, members of the Editorial Board, and/or appropriate
consultant reviewers. Reviewers' comments are usually returned to authors. The decision of the Editors is final. All authors are encourage
to submit manuscripts online via www.ees.elsevier.com/dsx and authors
who prefer sending the manuscripts via mail or email can send them to Dr S.M. Sadikot, the Editor in Chief at:
